Legacy Pharmaceutical Recalls Metformin Tablets Due to Foreign Imprint
Legacy Pharmaceutical Packaging LLC is recalling 111,948 bottles of Metformin Hydrochloride 1000 mg tablets because tablets with different imprints were found in the bottles.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which is defined as unlikely to cause adverse health consequences. The hazard involves a labeling/identity discrepancy (different imprint) rather than a confirmed toxic contamination or immediate physical injury risk, fitting the Moderate category for minor labeling or packaging errors.
Plain-English summary
Legacy Pharmaceutical Packaging LLC is recalling 111,948 bottles of Metformin Hydrochloride Tablets USP, 1000 mg, 60-count bottles. The product is prescription-only and was distributed by Wal-Mart to distribution centers in Georgia and Arkansas. The specific lot number is 201626 with an expiration date of 08/2022.
The recall was initiated due to the presence of foreign tablets or capsules. Specifically, Metformin 1000 mg tablets with a different imprint than expected were found inside the bottles. This discrepancy indicates a potential mix-up during the packaging process.
Consumers who have purchased this specific lot of Metformin Hydrochloride Tablets should stop using the medication and contact their healthcare provider or pharmacist for guidance. The product was manufactured for Heritage Pharmaceuticals Inc. and packaged by Legacy Pharmaceutical Packaging LLC.
The recalled product
- Product
- Metformin Hydrochloride Tablets USP, 1000 mg, 60-count bottles, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc., East Brunswick, NJ 08816, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, Distributed by: Wal-Mart, Bentonville, AR 72716. NDC 68645
- Manufacturer
- Legacy Pharmaceutical Packaging LLC
- Category
- Drug — Prescription Medication
- Affected units
- 111,948
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 201626
- Exp. Date 08/2022
Distribution
Related recalls
Same manufacturer · Legacy Pharmaceutical Packaging LLC
See all →- HighSertraline Hydrochloride Tablets Recalled Due to Manufacturing Process Defect
FDA (Drugs) · 2024-01-03
- SevereLosartan Potassium Tablets Recalled Due to Trace Nitrosamine Impurity
FDA (Drugs) · 2019-05-08
- SevereLosartan Potassium Tablets Recalled Due to Impurity Detection
FDA (Drugs) · 2019-04-10
- SevereLosartan Potassium Tablets Recalled Due to Impurity Presence
FDA (Drugs) · 2019-03-27
- SevereLosartan Potassium Tablets Recalled Due to Impurity Detection
FDA (Drugs) · 2019-03-27
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02